Literature DB >> 26026653

Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs.

Rozh H Al-Mashhadi1, Martin M Bjørklund, Martin B Mortensen, Christina Christoffersen, Torben Larsen, Erling Falk, Jacob F Bentzon.   

Abstract

AIMS/HYPOTHESIS: Diabetes is associated with an increased risk of atherosclerotic cardiovascular disease, but whether there is a direct and independent role for impaired glucose control in atherogenesis remains uncertain. We investigated whether diabetes with poor glycaemic control would accelerate atherogenesis in a novel pig model of atherosclerosis, the D374Y-PCSK9(+) transgenic minipig.
METHODS: Nineteen minipigs were fed a cholesterol-enriched, high-fat diet; ten of these pigs were injected with streptozotocin to generate a model of diabetes. Restricted feeding was implemented to control the pigs' weight gain and cholesterol intake. After 49 weeks of high-fat feeding, the major arteries were harvested for a detailed analysis of the plaque burden and histological plaque type.
RESULTS: Stable hyperglycaemia was achieved in the diabetic minipigs, while the plasma total and LDL-cholesterol and creatinine levels were unaffected. Diabetes failed to increase atherosclerosis in any of the vessels examined. The plaque burden in the aorta and right coronary artery was comparable between the groups, and was even reduced in the left anterior descending (LAD) coronary and iliofemoral arteries in the diabetic pigs compared with the controls. The distribution of plaque types and the collagen and macrophage contents were similar between the groups, except for a reduced infiltration of macrophages in the LAD arteries of the diabetic pigs. CONCLUSIONS/
INTERPRETATION: Poorly controlled diabetes with no alterations in plasma cholesterol or creatinine concentrations did not augment the plaque burden or promote the development of more advanced lesions in this large-animal model of human-like atherosclerosis. This is consistent with clinical studies in patients with type 1 diabetes, indicating that hyperglycaemia per se is not an independent promoter of atherosclerotic disease, but that other diabetes-associated risk factors are important.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26026653     DOI: 10.1007/s00125-015-3637-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

1.  Predictors of incident albuminuria in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Ashish Upadhyay; James B Meigs; Caroline S Fox
Journal:  Am J Kidney Dis       Date:  2010-11       Impact factor: 8.860

2.  Studies on the energy metabolism of pig red cells. I. The limiting role of membrane permeability in glycolysis.

Authors:  H D Kim; T J McManus
Journal:  Biochim Biophys Acta       Date:  1971-01-26

Review 3.  Atherosclerotic lesions in mouse and man: is it the same disease?

Authors:  Jacob Fog Bentzon; Erling Falk
Journal:  Curr Opin Lipidol       Date:  2010-10       Impact factor: 4.776

4.  Diabetes-induced accelerated atherosclerosis in swine.

Authors:  R G Gerrity; R Natarajan; J L Nadler; T Kimsey
Journal:  Diabetes       Date:  2001-07       Impact factor: 9.461

5.  Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease.

Authors:  Damir Hamamdzic; Robert S Fenning; Dhavalkumar Patel; Emile R Mohler; Ksenia A Orlova; Alexander C Wright; Raul Llano; Martin G Keane; Richard P Shannon; Morris J Birnbaum; Robert L Wilensky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-02       Impact factor: 4.733

6.  The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.

Authors:  Adriana Zuccollo; Chaomei Shi; Roberto Mastroianni; Karlene A Maitland-Toolan; Robert M Weisbrod; Mengwei Zang; Shanqin Xu; Bingbing Jiang; Jennifer M Oliver-Krasinski; Antonio J Cayatte; Stefano Corda; Gilbert Lavielle; Tony J Verbeuren; Richard A Cohen
Journal:  Circulation       Date:  2005-10-31       Impact factor: 29.690

7.  Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis.

Authors:  Song Chai; Qing Chai; Carl C Danielsen; Peter Hjorth; Jene R Nyengaard; Thomas Ledet; Yu Yamaguchi; Lars M Rasmussen; Lise Wogensen
Journal:  Circ Res       Date:  2005-02-10       Impact factor: 17.367

8.  Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.

Authors:  P Keren; J George; A Shaish; H Levkovitz; Z Janakovic; A Afek; I Goldberg; J Kopolovic; G Keren; D Harats
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

9.  Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes.

Authors:  Jon C Olson; John R Erbey; Kimberly Y Z Forrest; Katherine Williams; Dorothy J Becker; Trevor J Orchard
Journal:  Metabolism       Date:  2002-02       Impact factor: 8.694

10.  Reduction of cardiac functional reserve and elevation of aortic stiffness in hyperlipidemic Yucatan minipigs with systemic and coronary atherosclerosis.

Authors:  Yi-Xin Wang; Rick Fitch; Weiwei Li; Matthias Werner; Meredith Halks-Miller; Bill Lillis; Ronald Vergona; Joe Post; Mark E Sullivan; Peter F Verhallen
Journal:  Vascul Pharmacol       Date:  2002-07       Impact factor: 5.773

View more
  14 in total

Review 1.  Does Elevated Glucose Promote Atherosclerosis? Pros and Cons.

Authors:  Karin E Bornfeldt
Journal:  Circ Res       Date:  2016-07-08       Impact factor: 17.367

2.  Absence of Nicotinamide Nucleotide Transhydrogenase in C57BL/6J Mice Exacerbates Experimental Atherosclerosis.

Authors:  Aimee E Vozenilek; Matthew Vetkoetter; Jonette M Green; Xinggui Shen; James G Traylor; Ronald L Klein; A Wayne Orr; Matthew D Woolard; David M Krzywanski
Journal:  J Vasc Res       Date:  2018-02-16       Impact factor: 1.934

3.  Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes.

Authors:  Hendawy Om; Mehrez E El-Naggar; Mona El-Banna; Moustafa M G Fouda; Sarah I Othman; Ahmed A Allam; Osama M Morsy
Journal:  Invest New Drugs       Date:  2020-02-11       Impact factor: 3.850

Review 4.  Animal models of obesity and diabetes mellitus.

Authors:  Maximilian Kleinert; Christoffer Clemmensen; Susanna M Hofmann; Mary C Moore; Simone Renner; Stephen C Woods; Peter Huypens; Johannes Beckers; Martin Hrabe de Angelis; Annette Schürmann; Mostafa Bakhti; Martin Klingenspor; Mark Heiman; Alan D Cherrington; Michael Ristow; Heiko Lickert; Eckhard Wolf; Peter J Havel; Timo D Müller; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2018-01-19       Impact factor: 43.330

5.  A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification.

Authors:  Claudia Goettsch; Joshua D Hutcheson; Sumihiko Hagita; Maximillian A Rogers; Michael D Creager; Tan Pham; Jung Choi; Andrew K Mlynarchik; Brett Pieper; Mads Kjolby; Masanori Aikawa; Elena Aikawa
Journal:  Atherosclerosis       Date:  2016-06-09       Impact factor: 5.162

6.  Göttingen minipig model of diet-induced atherosclerosis: influence of mild streptozotocin-induced diabetes on lesion severity and markers of inflammation evaluated in obese, obese and diabetic, and lean control animals.

Authors:  Trine Pagh Ludvigsen; Rikke Kaae Kirk; Berit Østergaard Christoffersen; Henrik Duelund Pedersen; Torben Martinussen; Jonas Kildegaard; Peter M H Heegaard; Jens Lykkesfeldt; Lisbeth Høier Olsen
Journal:  J Transl Med       Date:  2015-09-22       Impact factor: 5.531

7.  Alloxan-induced diabetes exacerbates coronary atherosclerosis and calcification in Ossabaw miniature swine with metabolic syndrome.

Authors:  Jill K Badin; Ayeeshik Kole; Benjamin Stivers; Victor Progar; Anisha Pareddy; Mouhamad Alloosh; Michael Sturek
Journal:  J Transl Med       Date:  2018-03-09       Impact factor: 5.531

Review 8.  Cardiovascular disease in diabetes, beyond glucose.

Authors:  Robert H Eckel; Karin E Bornfeldt; Ira J Goldberg
Journal:  Cell Metab       Date:  2021-07-21       Impact factor: 31.373

9.  Models for preclinical studies in aging-related disorders: One is not for all.

Authors:  Gaetano Santulli; Consuelo Borras; Jean Bousquet; Laura Calzà; Antonio Cano; Maddalena Illario; Claudio Franceschi; Giuseppe Liotta; Marcello Maggio; William D Molloy; Nunzia Montuori; Rónán O'Caoimh; Francesc Orfila; Amelia P Rauter; Aurelia Santoro; Guido Iaccarino
Journal:  Transl Med UniSa       Date:  2016-01-31

Review 10.  The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol.

Authors:  Nabil G Seidah
Journal:  Glob Cardiol Sci Pract       Date:  2017-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.